PUBLISHER: Grand View Research | PRODUCT CODE: 1375954
PUBLISHER: Grand View Research | PRODUCT CODE: 1375954
The global pediatric perfusion market size is expected to reach USD 829.1 million by 2030, registering a CAGR of 5.4 % over the forecast period, according to a new report by Grand View Research, Inc.. The demand for pediatric perfusion is growing due to a rise in organ transplantations, increasing awareness regarding heart abnormalities and related treatments among parents, increased prevalence of congenital heart disease (CHD), and the growing number of cardiac surgeries. According to the American Heart Association, approximately 40,000 infants are expected to be affected by CHD in the U.S. annually. Around 25% of them require invasive treatment within their first year of birth.Thus, the growing prevalence of CHD among infants propels the demand for pediatric perfusions.
Moreover, increased healthcare expenditure and awareness about heart-related diseases and treatments, specifically in developed countries, have encouraged hospitals and healthcare facilities to invest in advanced pediatric perfusion equipment. For instance, according to the Centers for Medicare & Medicaid Services, national healthcare expenditure increased by 4.3% in 2022, with hospital care spending of about 0.8%. These factors are attributed to the growth of the pediatric perfusion industry.